Art

J-GLOBAL ID：200902255072547357   Reference number：08A0404237

抗精神病薬の非定型性をもたらすもの

Author (1)： MURASAKI MITSUKUNI (CNS薬理研)
Material： 臨床精神薬理  (Japanese Journal of Clinical Psychopharmacology)
Volume： 11  Issue： 5  Page： 795-806  Publication year： May. 10, 2008 
JST Material Number： L3883A  ISSN： 1343-3474  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *antipsychotic agent ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0404237&from=J-GLOBAL&jstjournalNo=L3883A") }}

JST classification (1)： Clinical application of psychotropic drugs  (GW03110J)

Substance index (3)： Chlorpromazine ,  Haloperidol ,  Clozapine

Reference (46)：

• Boyer, P., Lecrubier, Y., Puech, A. J. et al.: Treatment of negative symptoms in schizophrenia with amisulpiride. Br. J. Psychiatry, 166: 68-72, 1995.
• Burris, K. D., Molski, T. F., Xu, C. et al.: Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D₂ receptors. J. Pharmacol. Exp. Ther., 302: 381-389, 2002.
• Carlsson, A.: Antipsychotic drugs, neurotransmitters and schizophrenia. Am. J. Psychiatry, 135: 165-173, 1978.
• Carlsson, A., Lindqvist, M.: Effects of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol., 20: 140-144, 1963.
• Claghorn, J., Honigfeld, G., Abuzzahab, F. S. et al.: The risks and benefits of clozapine versus chlorpromazine. J. Clin. Psychopharmacol., 7: 377-384, 1987.

Terms in the title (2)： 抗精神病薬 ,  定型